Oxybutynin chloride extended-release tablets 5mg/tab, 2 tab, PO, qd.: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Oxybutynin chloride extended-release tablets 5mg/tab, 2 tab, PO, qd.

• Oxybutynin ER to Promote Early Continence Recovery After Robotic Prostatectomy: A Randomized Controlled Trial
  NCT06966778 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location

Common questions

How many recruiting trials involve Oxybutynin chloride extended-release tablets 5mg/tab, 2 tab, PO, qd.?

1 recruiting trial across 3 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.